NASDAQ: EXAS 45.96
Change: +0.96 +2.13% Minimum 20 min delay
3:59 PM ET on Sep 22, 2017
Volume: 2,154,532

OUR FIRST MISSION:

To work with patients, payers & providers to help play a role in the eradication of colorectal cancer.

Exact Sciences Laboratories

How our lab’s technologies and efficiencies carry Cologuard from arrival to result.

The Exact Science of Customer Care

Supporting patients and driving compliance is a science all its own. Learn how we practice it.

Tennis Anyone?

How Cologuard's keeping Steve Rubin on the court and bringing physicians into play.

Latest Financial Reports

Current Corporate Presentation

Corporate Presentation - September 2017 September 1, 2017
Download (PDF 1.46 MB)